DT
PCRX icon

Diversified Trust’s Pacira BioSciences PCRX Stock Holding History

Diversified Trust’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		$391K Buy
+4,260
New +$324K 0.03% 417

Other funds holding PCRX

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
DCM
Daruma Capital Management New York $879M AUM 2.11% 1-Year Est. Return
MCM
Marsico Capital Management Denver, Colorado $3.4B AUM 51.58% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
NCGI
Next Century Growth Investors Plymouth, Minnesota $1.38B AUM 102.34% 1-Year Est. Return

Diversified Trust's PCRX Position: Q2 2014 in Review

Diversified Trust opened a new position in Pacira BioSciences (PCRX) in Q2 2014: 4,260 shares worth $391K. The stake represents 0.03% of the portfolio and ranks #417 among its holdings.

191 funds tracked by Wall St. Rank hold PCRX as of Q2 2014.

  • Diversified Trust held 4,260 shares of Pacira BioSciences worth $391K as of Q2 2014.
  • Pacira BioSciences was a new Diversified Trust position in Q2 2014.
  • Pacira BioSciences made up 0.03% of Diversified Trust's portfolio in Q2 2014, its #417 holding.
  • 191 funds tracked by Wall St. Rank held Pacira BioSciences as of Q2 2014.

Based on Diversified Trust's 13F filing for Q2 2014, filed 15 Aug 2014.